纵横研报
Ticker Detail

688068.SHG

¥139+11.15% 热景生物 Biotechnology
00Reports China 医疗健康
Beijing Hotgen Biotech Co Ltd
医疗健康 · 生物科技

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers nucleic acid drugs, antibody drugs, and biotechnology health and beauty consumer products. The company also provides clinical diagnostics and product solutions, including Upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.

MARKET 市值 11.53B CNY 52W ¥73.44 – ¥262.22 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 24.4% ROE -10.7% 营业利润率 -71.2% 净利润率 -57.7%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制